Log in to save to my catalogue

Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia

Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2885537100

Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia

About this item

Full title

Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2023-11, Vol.389 (18), p.1649-1659

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

Recurrent bleeding from the small intestine accounts for 5 to 10% of cases of gastrointestinal bleeding and remains a therapeutic challenge. Thalidomide has been evaluated for the treatment of recurrent bleeding due to small-intestinal angiodysplasia (SIA), but confirmatory trials are lacking.
We conducted a multicenter, double-blind, randomized...

Alternative Titles

Full title

Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2885537100

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2885537100

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2303706

How to access this item